Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Iván Álvarez-Twose"'
Autor:
Aniza Giacaman, José Antonio Salinas Sanz, Mercedes Guibelalde, Iván Álvarez-Twose, Ana Martín-Santiago
Publikováno v:
Anales de Pediatría (English Edition), Vol 99, Iss 5, Pp 350-351 (2023)
Externí odkaz:
https://doaj.org/article/f31b6e8a3b6b416890e22dbfb9da218b
Autor:
Alba Pérez‐Pons, María Jara‐Acevedo, Ana Henriques, Paula Navarro‐Navarro, Andrés C. García‐Montero, Iván Álvarez‐Twose, Carlos E. Pedreira, Laura Sánchez‐Muñoz, Daniela Damasceno, Carolina Caldas, Javier I. Muñoz‐González, Almudena Matito, Juan Flores‐Montero, Oscar González‐López, Ignacio Criado, Andrea Mayado, Alberto Orfao
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 6, Pp n/a-n/a (2022)
Abstract Background Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investi
Externí odkaz:
https://doaj.org/article/dd7db6ae0e5a44aeb3411ba56ebf9c86
Autor:
María González-Tablas, Carlos Prieto, Daniel Arandia, María Jara-Acevedo, Álvaro Otero, Daniel Pascual, Laura Ruíz, Iván Álvarez-Twose, Andrés Celestino García-Montero, Alberto Orfao, María Dolores Tabernero
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Human WHO grade 1 meningiomas are generally considered benign tumors; despite this, they account for ≈50% of all recurrent meningiomas. Currently, limited data exist about the mutational profiles of grade 1 meningiomas and patient outcome. We inves
Externí odkaz:
https://doaj.org/article/651bc04a5fbc4ef3baa4c70aeaba289e
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The prevalence of anaphylaxis among patients with clonal mast cell disorders (MCD) is clearly higher comparing to the general population. Due to a lower frequency of symptoms outside of acute episodes, clonal MCD in the absence of skin lesions might
Externí odkaz:
https://doaj.org/article/b638d9fd6f9f4b0090ad6ccc88827b6c
Autor:
Almudena Matito, José Mario Morgado, Iván Álvarez-Twose, Laura Sánchez-Muñoz, Carlos Eduardo Pedreira, María Jara-Acevedo, Cristina Teodosio, Paula Sánchez-López, Elisa Fernández-Núñez, Ricardo Moreno-Borque, Andrés García-Montero, Alberto Orfao, Luis Escribano
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76116 (2013)
BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease beha
Externí odkaz:
https://doaj.org/article/221727acaa9e4604934729ea92d4ba2b
Autor:
Tiago Azenha Rama, Ana Filipa Henriques, Almudena Matito, Maria Jara-Acevedo, Carolina Caldas, Andrea Mayado, Javier I. Muñoz-González, André Moreira, João Cavaleiro-Rufo, Andrés García-Montero, Alberto Órfão, Laura Sanchez-Muñoz, Iván Álvarez-Twose
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 11:1536-1547
Autor:
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H. Radia, Johannes Lübke, Priyanka J. Bobbili, Aolin Wang, Chelsea Norregaard, Saša Dimitrijevic, Erin Sullivan, Melinda Louie-Gao, Juliana Schwaab, Ilene A. Galinsky, Cecelia Perkins, Wolfgang R. Sperr, Priya Sriskandarajah, Andi Chin, Selvam R. Sendhil, Mei Sheng Duh, Peter Valent, Daniel J. DeAngelo
Publikováno v:
Leukemia. 36:2108-2120
Advanced systemic mastocytosis (AdvSM) is a rare myeloid neoplasm associated with poor overall survival (OS). This study (NCT04695431) compared clinical outcomes between patients with AdvSM treated with avapritinib in the Phase 1 EXPLORER (NCT0256198
Autor:
Andrea Mayado, Iván Álvarez-Twose, María Jara-Acevedo, Ana Gabriela Henriques, Javier I. Muñoz-González, Laura Sánchez-Muñoz, Alba Pérez-Pons, Alberto Orfao, Carolina Caldas, Lidia Torres-Rivera, Andrés C. García-Montero, Almudena Matito
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Circulating tumor mast cells (CTMCs) have been identified in the blood of a small number of patients with advanced systemic mastocytosis (SM). However, data are limited about their frequency and prognostic impact in patients with MC activation syndro
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:427-434
[Objective]: Mast cell (MC) activation (MCA) defines the mechanism by which certain patients have symptoms owing to the effect of a wide range of mediators released from MCs upon their activation, when triggered by different stimuli. When these sympt
Autor:
Paula Navarro‐Navarro, Iván Álvarez‐Twose, Alba Pérez‐Pons, Ana Henriques, Andrea Mayado, Andrés C. García‐Montero, Laura Sánchez‐Muñoz, Oscar González‐López, Almudena Matito, Carolina Caldas, María Jara‐Acevedo, Alberto Orfao
Publikováno v:
AllergyREFERENCES.
Current diagnostic algorithms for systemic mastocytosis (SM) rely on the detection of KITD816V in blood to trigger subsequent bone marrow (BM) investigations.Here, we correlated the KITD816V mutational status of paired blood and BM samples from 368 a